Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SHANGHAI PECHEM
00338
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -50.11%206.32M | 34.78%187.26M | 19.64%413.55M | -62.32%138.94M | 1,339.61%345.65M | 1,269.72%368.7M | -103.25%-27.88M | -94.65%26.92M | -22.34%857.82M | 84.73%502.96M |
| Operating income | -50.11%206.32M | 34.78%187.26M | 19.64%413.55M | -62.32%138.94M | 1,339.61%345.65M | 1,269.72%368.7M | -103.25%-27.88M | -94.65%26.92M | -22.34%857.82M | 84.73%502.96M |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Employee expense | 1.93%-156.4M | 8.48%-74.16M | 8.26%-159.48M | 0.97%-81.03M | -4.79%-173.83M | 8.72%-81.83M | 10.90%-165.88M | 9.08%-89.64M | 27.05%-186.18M | 20.31%-98.6M |
| Depreciation and amortization | 16.35%-16.39M | 14.01%-8.74M | 38.50%-19.59M | 47.08%-10.17M | 24.04%-31.86M | 10.42%-19.21M | 8.44%-41.94M | 8.88%-21.45M | 5.05%-45.81M | -1.92%-23.54M |
| Revaluation surplus | -309.09%-17.94M | ---14.04M | 120.37%8.58M | ---- | ---42.12M | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of investment property | -309.09%-17.94M | ---14.04M | 120.37%8.58M | ---- | ---42.12M | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | -361.06%-55.47M | -79.40%9.36M | -65.71%21.25M | 195.10%45.45M | 105.81%61.95M | 40.68%-47.79M | 58.71%-1.07B | 65.63%-80.57M | -593.08%-2.58B | -93.35%-234.44M |
| -Other impairment is provision | -361.06%-55.47M | -79.40%9.36M | -65.71%21.25M | 195.10%45.45M | 105.81%61.95M | 40.68%-47.79M | 58.71%-1.07B | 65.63%-80.57M | -593.08%-2.58B | -93.35%-234.44M |
| Operating interest expense | 28.34%-37.54M | 13.28%-23.03M | -6.11%-52.39M | 1.64%-26.56M | 1.95%-49.37M | -10.14%-27M | 19.36%-50.36M | 26.46%-24.52M | 43.14%-62.44M | 45.78%-33.34M |
| Special items of operating profit | 48.26%-156.29M | 2.74%-74.28M | -3,810.05%-302.07M | 1.66%-76.37M | 103.52%8.14M | -10.55%-77.66M | -26.93%-231.08M | 27.22%-70.26M | 10.54%-182.05M | 9.99%-96.53M |
| Operating profit | -159.23%-233.7M | 124.36%2.37M | -176.04%-90.15M | -108.45%-9.73M | 107.49%118.57M | 144.39%115.2M | 28.06%-1.58B | -1,671.38%-259.51M | -2,010.83%-2.2B | 110.04%16.52M |
| Share of profits of associates | ---- | ---- | 3,573.20%24.1M | --21.49M | -24.82%-694K | ---- | -205.70%-556K | -42.35%-242K | 355.34%526K | -431.25%-170K |
| Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 182.86%1.55M | -185.94%-428K |
| Earning before tax | -253.83%-233.7M | -79.84%2.37M | -156.03%-66.05M | -89.79%11.76M | 107.44%117.87M | 144.35%115.2M | 27.97%-1.58B | -1,731.93%-259.76M | -2,044.12%-2.2B | 109.70%15.92M |
| Tax | 59.22%-2.98M | 125.42%152K | -539.26%-7.32M | 84.79%-598K | 224.12%1.67M | -127.76%-3.93M | 100.84%514K | 802.58%14.16M | -522.02%-61.39M | -182.12%-2.02M |
| After-tax profit from continuing operations | -222.61%-236.69M | -77.40%2.52M | -161.38%-73.37M | -89.97%11.16M | 107.55%119.54M | 145.31%111.27M | 29.94%-1.58B | -1,866.71%-245.59M | -2,289.42%-2.26B | 108.60%13.9M |
| Earning after tax | -222.61%-236.69M | -77.40%2.52M | -161.38%-73.37M | -89.97%11.16M | 107.55%119.54M | 145.31%111.27M | 29.94%-1.58B | -1,866.71%-245.59M | -2,289.42%-2.26B | 108.60%13.9M |
| Profit attributable to shareholders | -222.61%-236.69M | -77.40%2.52M | -161.38%-73.37M | -89.97%11.16M | 107.55%119.54M | 145.31%111.27M | 29.94%-1.58B | -1,866.71%-245.59M | -2,289.42%-2.26B | 108.60%13.9M |
| Dividend per share | ---- | ---- | ---- | ---- | ---- | --0.011 | ---- | ---- | ---- | ---- |
| Basic earnings per share | -225.00%-0.039 | -77.78%0.0004 | -163.16%-0.012 | -90.00%0.0018 | 107.31%0.019 | 145.00%0.018 | 29.73%-0.26 | -1,839.13%-0.04 | -2,302.38%-0.37 | 108.75%0.0023 |
| Diluted earnings per share | -225.00%-0.039 | -77.78%0.0004 | -163.16%-0.012 | -90.00%0.0018 | 107.31%0.019 | 145.00%0.018 | 29.73%-0.26 | -1,839.13%-0.04 | -2,302.38%-0.37 | 108.75%0.0023 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | KPMG | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.